Matches in Wikidata for { <http://www.wikidata.org/entity/Q91870882> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91870882 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91870882 description "scientific article published on 08 May 2019" @default.
- Q91870882 description "wetenschappelijk artikel" @default.
- Q91870882 description "наукова стаття, опублікована 8 травня 2019" @default.
- Q91870882 name "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 name "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 type Item @default.
- Q91870882 label "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 label "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 prefLabel "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 prefLabel "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 P1433 Q91870882-25046748-CC36-4152-8AEA-829C76388EBF @default.
- Q91870882 P1476 Q91870882-AECAF896-E52A-44F8-BC89-64665CCEEF61 @default.
- Q91870882 P2093 Q91870882-55AE5999-5840-47A4-94B4-2E2FF9F0F77C @default.
- Q91870882 P2093 Q91870882-B1A94FF4-2BD3-4BBD-B137-9778B3DF834E @default.
- Q91870882 P2093 Q91870882-D5298764-6339-4820-91B9-91A244C2ACE7 @default.
- Q91870882 P2093 Q91870882-D9F8B92E-20EA-4D88-85D2-209F9C27B982 @default.
- Q91870882 P2093 Q91870882-E640B521-56DC-4BE9-BF70-45F129AF56BE @default.
- Q91870882 P304 Q91870882-929AB7AF-D08C-49A3-B38D-C4B5C12499B4 @default.
- Q91870882 P31 Q91870882-3A6A2A38-2D4F-4E0E-AD2C-A38B590098F2 @default.
- Q91870882 P356 Q91870882-772DFF6C-C924-4FEB-B7DB-7F49A622D19F @default.
- Q91870882 P433 Q91870882-739650B2-4DCD-4DA6-9FC3-9F895D8BA425 @default.
- Q91870882 P478 Q91870882-0F1898AE-0297-4163-8292-248F2FE3CE6E @default.
- Q91870882 P50 Q91870882-8F73F379-D826-49DA-A9A1-29C3FE04CBDB @default.
- Q91870882 P50 Q91870882-90731816-3A6E-4DCF-AAA8-E50E3BA12C01 @default.
- Q91870882 P50 Q91870882-D0ADDF5E-F39D-4268-9B9F-7A77AC9DCD75 @default.
- Q91870882 P577 Q91870882-8CD21C80-6AE7-4307-9ADF-0878AEC51F81 @default.
- Q91870882 P698 Q91870882-F44500E4-D2CF-492C-8488-0C690A9A18EA @default.
- Q91870882 P921 Q91870882-2B338CCD-81FC-40B2-82A5-A7AD519E7036 @default.
- Q91870882 P356 S00262-019-02331-X @default.
- Q91870882 P698 31069460 @default.
- Q91870882 P1433 Q5031409 @default.
- Q91870882 P1476 "First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1" @default.
- Q91870882 P2093 "Hailing Lu" @default.
- Q91870882 P2093 "Jan H Ter Meulen" @default.
- Q91870882 P2093 "Richard Kenney" @default.
- Q91870882 P2093 "Samuel Ejadi" @default.
- Q91870882 P2093 "Seunghee Kim-Schulze" @default.
- Q91870882 P304 "1211-1222" @default.
- Q91870882 P31 Q13442814 @default.
- Q91870882 P356 "10.1007/S00262-019-02331-X" @default.
- Q91870882 P433 "7" @default.
- Q91870882 P478 "68" @default.
- Q91870882 P50 Q108791503 @default.
- Q91870882 P50 Q38296739 @default.
- Q91870882 P50 Q79225628 @default.
- Q91870882 P577 "2019-05-08T00:00:00Z" @default.
- Q91870882 P698 "31069460" @default.
- Q91870882 P921 Q5452194 @default.